ALTAIR Study: Trifluridine/Tipiracil vs Placebo in Patients With Molecular Residual Disease Following Curative Resection of CRC.
Saved in:
| Title: | ALTAIR Study: Trifluridine/Tipiracil vs Placebo in Patients With Molecular Residual Disease Following Curative Resection of CRC. |
|---|---|
| Source: | Clinical advances in hematology & oncology: H&O 2025 Supplement; Vol. 23. |
| Journal Info: | Publisher: Millennium Medical Publishing, Inc. ISSN: 1543-0790 |
| Database: | MEDLINE Ultimate |
| ISSN: | 1543-0790 |
|---|
